This special issue represents recent proceedings and developments in the fields of nitrite and nitrate chemistry, biology and therapeutics that were discussed at the biannual international meeting entitled “Approaching the Clinic: Nitrite and Nitrate Pathophysiology and Therapy Conference”. This conference represents the fourth instillation of this meeting series that has served as a unique forum where investigators from diverse backgrounds have come together to better understand the chemical biology of nitrite and nitrate with an emphasis on therapeutic utility of nitrite and nitrate for various disease conditions.
Over the three-day meeting, new information was shared regarding the biological importance of nitrite and nitrate mediated nitric oxide (NO) formation for numerous aspects of physiological homeostasis and disease states. Initial studies regarding nitrite biology and function elucidated biochemical mechanisms involved in nitrite reduction to NO under specific conditions such as tissue ischemia [1]. However, meeting presentations demonstrated that therapeutic benefits of nitrite might be more broadly beneficial than previously considered for several cardiovascular pathologies such as vascular intimal hyperplasia and vascular aging, and chemotherapeutic cardiotoxicity [2; 3; 4]. New findings were also discussed regarding the relationship between myoglobin and mitochondrial function with respect to hypoxia and nitrite/NO metabolism that are further discussed in this issue [5; 6]. Lastly, clinical and translational studies were discussed regarding the safety and efficacy of nitrite therapy for peripheral vascular diseases that are currently under way [7].
Nitrate and nitrite work in coordination with nitric oxide synthase (NOS) enzymes to establish a unique and dynamic NO endocrine system that is operational throughout the body [8; 9]. Data was presented showing that nitrate consumption augments vascular compliance but did not alter flow-mediated vasodilation in healthy subjects [10]. Presentations also discussed biochemical and physiological similarities and differences between various organic versus inorganic nitrates and nitrites as it is now clear that these compounds are metabolized in diverse ways and can elicit different biological responses that could be harnessed for various therapeutic uses [11; 12].
With a significant theme of the conference focused on translational and therapeutic implications of nitrite and nitrate, both novel uses and potential limitations were actively discussed. New evidence has emerged that exogenous nitrite can stimulate significant biological responses in different cell types under normal oxygen tensions. In particular, nitrite enhances lung epithelial cell activation under normoxic conditions through redox signaling pathways [13]. Evidence was also presented demonstrating that nitrite therapy is neuroprotective after cardiac arrest reinforcing its utility as a cytoprotective agent [14]. Conversely, safety concerns surrounding nitrite and nitrate were also discussed based on previous and recent studies [15]. Careful comparison and evaluation across multiple areas of investigation further revealed that nitrite/nitrate adverse effects and toxicity to be significantly above therapeutic amounts that have been used by numerous investigators [8; 9]. Nonetheless, it was acknowledged that close evaluation and monitoring of adverse events and toxicity are critical for therapeutic studies moving forward.
In summary, results from the 4th biannual Nitrite and Nitrate meeting provided important and unique insight into the different therapeutic directions that are emerging. Significant interest on this and other biochemical and pathophysiological topics from both academic and industry sectors highlight that the field of Nitrite and Nitrate chemical biology is continuing to mature and progressing toward the realization of useful therapeutics for numerous disease conditions involving dysfunctional NO metabolism and bioavailability.
Footnotes
Conflicts of Interest
C.G.K. and D.J.L. are listed on intellectual property using nitrite for ischemia and cardiovascular disease. C.G.K. has a commercial interest in TheraVasc Inc.
References
- 1.Calvert JW, Lefer DJ. Clinical translation of nitrite therapy for cardiovascular diseases. Nitric Oxide. 2010;22:91–7. doi: 10.1016/j.niox.2009.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Alef MJ, Tzeng E, Zuckerbraun BS. Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.014. [DOI] [PubMed] [Google Scholar]
- 3.Xi L, Zhu SG, Das A, Chen Q, Durrant D, Hobbs DC, Lesnefsky EJ, Kukreja RC. Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sindler AL, Fleenor BS, Calvert JW, Marshall KD, Zigler ML, Lefer DJ, Seals DR. Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging. Aging Cell. 2011;10:429–37. doi: 10.1111/j.1474-9726.2011.00679.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kamga C, Krishnamurthy S, Shiva S. Myoglobin and mitochondria: A relationship bound by oxygen and nitric oxide. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Totzeck M, Hendgen-Cotta UB, Rammos C, Petrescu AM, Meyer C, Balzer J, Kelm M, Rassaf T. Assessment of the functional diversity of human myoglobin. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.001. [DOI] [PubMed] [Google Scholar]
- 7.Allen JD, Giordano T, Kevil CG. Nitrite and nitric oxide metabolism in peripheral artery disease. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kevil CG, Kolluru GK, Pattillo CB, Giordano T. Inorganic nitrite therapy: historical perspective and future directions. Free Radic Biol Med. 2011;51:576–93. doi: 10.1016/j.freeradbiomed.2011.04.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7:156–67. doi: 10.1038/nrd2466. [DOI] [PubMed] [Google Scholar]
- 10.Bahra M, Kapil V, Pearl V, Ghosh S, Ahluwalia A. Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Omar SA, Artime E, Webb AJ. A comparison of organic and inorganic nitrates/nitrites. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.008. [DOI] [PubMed] [Google Scholar]
- 12.Nossaman BD, Pankey EA, Badejo AR, Jr, Casey DB, Uppu S, Murthy SN, Kadowitz PJ. Analysis of responses to glyceryl trinitrate and sodium nitrite in the intact chest rat. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang L, Frizzell SA, Zhao X, Gladwin MT. Normoxic cyclic GMP-independent oxidative signaling by nitrite enhances airway epithelial cell proliferation and wound healing. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Dezfulian C, Alekseyenko A, Dave KR, Raval AP, Do R, Kim F, Perez-Pinzon MA. Nitrite therapy is neuroprotective and safe in cardiac arrest survivors. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sindelar JJ, Milkowski AL. Human safety controversies surrounding nitrate and nitrite in the diet. Nitric Oxide. 2012 doi: 10.1016/j.niox.2012.03.011. [DOI] [PubMed] [Google Scholar]